Measuring the impact of monoclonal antibody therapies

OBJECTIVE: Monoclonal antibody (Mab) treatments have significantly improved the quality and quantity of life, but they are some of the most expensive treatments, resulting in a degree of hesitancy to introduce new Mab agents. A system for estimating the effect of Mab drugs, in general, would optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ka Keat, Ng, Kenrick, Balachandran, Sathiyaa, Russell, Mark D., Boalch, Amy, Sinclair, Alasdair, Coker, Bolaji, Vinnakota, Krishna, Mansoor, Rashid, Douiri, Abdel, Marks, Lara V., Sacks, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690588/
https://www.ncbi.nlm.nih.gov/pubmed/38046416
http://dx.doi.org/10.3389/fmed.2023.1256712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690588/
https://www.ncbi.nlm.nih.gov/pubmed/38046416
http://dx.doi.org/10.3389/fmed.2023.1256712

Ejemplares similares